跳至主要内容
临床试验/RBR-8ht6j7q
RBR-8ht6j7q尚未招募3 期

icotinamide as chemoprevention of Skin Cancer in Transplant recipietns

Irmandade Santa Casa de Misericordia de Porto Alegre0 个研究点开始时间: 2021年3月16日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • Patients older than 18 years; transplanted at least one year ago; with diagnosis of at least two NMSC in the last 12 months; who accept to participate in the study and agree to take the medication or placebo, by signing an Informed Consent Form.

排除标准

  • Patients who do not wish to participate in the study; patients with impaired renal; hepatic or clotting function; patients who had malignant internal organ tumors in the last 5 years or malignant tumor metastases; pregnant or lactating women; patients on hemodialysis or peritoneal dialysis; patients who underwent treatment for actinic keratoses in the last 4 weeks; patients using systemic retinoids or with previous use of nicotinamide in the last 4 weeks

研究者

发起方
Irmandade Santa Casa de Misericordia de Porto Alegre

相似试验